{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T20:57:17Z","timestamp":1769115437990,"version":"3.49.0"},"reference-count":86,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sensors"],"abstract":"<jats:p>Diagnosing and treating acute coronary syndromes consumes a significant fraction of the healthcare budget worldwide. The pressure on resources is expected to increase with the continuing rise of cardiovascular disease, other chronic diseases and extended life expectancy, while expenditure is constrained. The objective of this review is to assess if home-based solutions for measuring chemical cardiac biomarkers can mitigate or reduce the continued rise in the costs of ACS treatment. A systematic review was performed considering published literature in several relevant public databases (i.e., PUBMED, Cochrane, Embase and Scopus) focusing on current biomarker practices in high-risk patients, their cost-effectiveness and the clinical evidence and feasibility of implementation. Out of 26,000 references screened, 86 met the inclusion criteria after independent full-text review. Current clinical evidence highlights that home-based solutions implemented in primary and secondary prevention reduce health care costs by earlier diagnosis, improved patient outcomes and quality of life, as well as by avoidance of unnecessary use of resources. Economical evidence suggests their potential to reduce health care costs if the incremental cost-effectiveness ratio or the willingness-to-pay does not surpass \u00a320,000\/QALY or \u20ac50,000 limit per 20,000 patients, respectively. The cost-effectiveness of these solutions increases when applied to high-risk patients.<\/jats:p>","DOI":"10.3390\/s20175006","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T08:40:26Z","timestamp":1599122426000},"page":"5006","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Benefits of Home-Based Solutions for Diagnosis and Treatment of Acute Coronary Syndromes on Health Care Costs: A Systematic Review"],"prefix":"10.3390","volume":"20","author":[{"given":"Pau","family":"Red\u00f3n","sequence":"first","affiliation":[{"name":"C\u00daRAM Center for Research in Medical Devices, H91 W2TY Galway, Ireland"},{"name":"Smart Sensor Lab, School of Medicine, National University of Ireland, Galway (NUIG), H91 TK33 Galway, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4741-4302","authenticated-orcid":false,"given":"Atif","family":"Shahzad","sequence":"additional","affiliation":[{"name":"Smart Sensor Lab, School of Medicine, National University of Ireland, Galway (NUIG), H91 TK33 Galway, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9505-2732","authenticated-orcid":false,"given":"Talha","family":"Iqbal","sequence":"additional","affiliation":[{"name":"Smart Sensor Lab, School of Medicine, National University of Ireland, Galway (NUIG), H91 TK33 Galway, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Wijns","sequence":"additional","affiliation":[{"name":"C\u00daRAM Center for Research in Medical Devices, H91 W2TY Galway, Ireland"},{"name":"Smart Sensor Lab, School of Medicine, National University of Ireland, Galway (NUIG), H91 TK33 Galway, Ireland"},{"name":"Saolta University Healthcare Group, University Hospital Galway, Newcastle Road, H91 YR71 Galway, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"ref_1","unstructured":"(2020, April 07). Cardiovascular Diseases (CVDs). Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/eurheartj\/ehx343","article-title":"Cardiomyocyte Renewal in the Human Heart: Insights from the Fall-Out","volume":"38","author":"Sadek","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2015.05.026","article-title":"Dynamics of Cell Generation and Turnover in the Human Heart","volume":"161","author":"Bergmann","year":"2015","journal-title":"Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth Universal Definition of Myocardial Infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"ref_5","unstructured":"World Health Organization (1971). Working Group on the Establishement of Ischemic Heart Disease Registers; Report of the Fifth Working Group, World Health Organization. Report No. Eur 8201 (5)."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","article-title":"Universal Definition of Myocardial Infarction","volume":"116","author":"Thygesen","year":"2007","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third Universal Definition of Myocardial Infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting with ST-Segment Elevation","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Twerenbold, R., Rubini Gimenez, M., Nestelberger, T., Boeddinghaus, J., Wildi, K., and Mueller, C. (2019). Optimising the Early Rule-out and Rule-in of Myocardial Infarction Using Biomarkers. Cardiovasc. Med., 22.","DOI":"10.4414\/cvm.2019.02010"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart Disease and Stroke Statistics\u20142018 Update: A Report From the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1185\/030079906X167462","article-title":"Acute Coronary Syndromes in Europe: 1-Year Costs and Outcomes","volume":"23","author":"Taylor","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jamacardio.2016.3855","article-title":"Intensive Care Unit Utilization and Mortality Among Medicare Patients Hospitalized With Non-ST-Segment Elevation Myocardial Infarction","volume":"2","author":"Fanaroff","year":"2017","journal-title":"JAMA Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e001290","DOI":"10.1161\/JAHA.114.001290","article-title":"Clinical Preventability of 30-Day Readmission after Percutaneous Coronary Intervention","volume":"3","author":"Wasfy","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., and Group, T.P. (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med., 6.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"ref_15","first-page":"723","article-title":"How to Prepare a Systematic Review of Economic Evaluations for Informing Evidence-Based Healthcare Decisions: Data Extraction, Risk of Bias, and Transferability (Part 3\/3)","volume":"16","author":"Wijnen","year":"2016","journal-title":"Expert Rev. Pharm. Outcomes Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: Advancing Guideline Development, Reporting and Evaluation in Healthcare","volume":"182","author":"Brouwers","year":"2010","journal-title":"Can. Med. Assoc. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrcardio.2017.48","article-title":"High-Sensitivity Assays for Troponin in Patients with Cardiac Disease","volume":"14","author":"Westermann","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Sherwood, M.W., and Kristin Newby, L. (2014). High-Sensitivity Troponin Assays: Evidence, Indications, and Reasonable Use. J. Am. Heart Assoc., 3.","DOI":"10.1161\/JAHA.113.000403"},{"key":"ref_19","unstructured":"Michos, E.D., Berger, Z., Yeh, H.-C., Suarez-Cuervo, C., Wilson, L.M., Stacy, S., and Bass, E.B. (2020, September 02). Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK241525\/."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/M14-0746","article-title":"Role of Troponin in Patients With Chronic Kidney Disease and Suspected Acute Coronary Syndrome: A Systematic Review","volume":"161","author":"Stacy","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/00365513.2016.1230886","article-title":"The Variation in High Sensitive Cardiac Troponin Concentration during Haemodialysis Treatment Is Not Similar to the Biological Variation Observed in Stable End Stage Renal Disease Patients","volume":"76","author":"Skadberg","year":"2016","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1161\/CIRCULATIONAHA.114.014245","article-title":"Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction","volume":"131","author":"Twerenbold","year":"2015","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2337\/dc16-1541","article-title":"High-Sensitivity Cardiac Troponin T (Hs-CTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study","volume":"40","author":"Whelton","year":"2017","journal-title":"Diabetes Care"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ferdinand, K.C., and Igari, M. (2017). Defining Cardiovascular Risk in Diabetes: The Emerging Role of Troponin Assays. J. Lab. Precis. Med., 2.","DOI":"10.21037\/jlpm.2017.06.10"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/eurheartj\/ehq251","article-title":"Recommendations for the Use of Cardiac Troponin Measurement in Acute Cardiac Care","volume":"31","author":"Thygesen","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/cvr\/cvx183","article-title":"Cardiac Troponins: From Myocardial Infarction to Chronic Disease","volume":"113","author":"Park","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_27","first-page":"187","article-title":"Increased Level of High-Sensitivity Cardiac Troponin T in a Geriatric Population Is Determined by Comorbidities Compared to Age","volume":"22","author":"Sedighi","year":"2019","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/eurheartj\/ehr033","article-title":"Early Diagnosis of Acute Myocardial Infarction in the Elderly Using More Sensitive Cardiac Troponin Assays","volume":"32","author":"Reiter","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.2169\/internalmedicine.8510-16","article-title":"Impact of Aging on High-Sensitivity Cardiac Troponin T in Patients Suspected of Acute Myocardial Infarction","volume":"56","author":"Ichise","year":"2017","journal-title":"Intern. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.archger.2016.03.010","article-title":"High-Sensitivity Cardiac Troponin T in Geriatric Inpatients","volume":"65","author":"Zhang","year":"2016","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jacc.2013.12.032","article-title":"Age and Sex Dependent Upper Reference Limits for the High Sensitivity Cardiac Troponin T Assay","volume":"63","author":"Gore","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_32","first-page":"1081","article-title":"Biomarkers of Acute Myocardial Infarction in the Elderly: Troponin and Beyond","volume":"9","author":"Rains","year":"2014","journal-title":"Clin. Interv. Aging"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ejhf.872","article-title":"Organ Dysfunction, Injury and Failure in Acute Heart Failure: From Pathophysiology to Diagnosis and Management. A Review on Behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC): Organ Dysfunction and Failure in AHF","volume":"19","author":"Harjola","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_34","first-page":"e240","article-title":"2013 ACCF\/AHA Guideline for the Management of Heart Failure","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.15420\/cfr.2015.1.2.102","article-title":"Role of Cardiac Troponin Levels in Acute Heart Failure","volume":"1","author":"Wettersten","year":"2015","journal-title":"Card. Fail. Rev."},{"key":"ref_36","first-page":"S21","article-title":"The Acute Decompensated Heart Failure National Registry (ADHERE): Opportunities to Improve Care of Patients Hospitalized with Acute Decompensated Heart Failure","volume":"4","author":"Fonarow","year":"2003","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ahj.2007.01.027","article-title":"Relation between Cardiac Troponin I and Mortality in Acute Decompensated Heart Failure","volume":"153","author":"You","year":"2007","journal-title":"Am. Heart J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11739-008-0092-8","article-title":"Cardiac Troponin I as Prognostic Marker in Heart Failure Patients Discharged from Emergency Department","volume":"3","author":"Parenti","year":"2008","journal-title":"Intern. Emerg. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S1053-2498(00)00120-0","article-title":"Cardiac Troponin I as Diagnostic and Prognostic Marker in Severe Heart Failure","volume":"19","author":"Vecchia","year":"2000","journal-title":"J. Heart Lung Transplant."},{"key":"ref_40","first-page":"404","article-title":"Cardiac Troponin T for Risk Stratification in Decompensated Chronic Heart Failure","volume":"92","author":"Latorre","year":"2009","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijcard.2004.01.017","article-title":"Minor Myocardial Damage Detected by Troponin T Is a Powerful Predictor of Long-Term Prognosis in Patients with Acute Decompensated Heart Failure","volume":"99","author":"Perna","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCHEARTFAILURE.111.961581","article-title":"Impact of Serial Troponin Release on Outcomes in Patients with Acute Heart Failure: Analysis from the PROTECT Pilot Study","volume":"4","author":"Fiuzat","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Westwood, M., Van Asselt, T., Ramaekers, B., Whiting, P., Thokala, P., Joore, M., Armstrong, N., Ross, J., Severens, J., and Kleijnen, J. (2015). Chapter 4, Assessment of Cost-Effectiveness. High-Sensitivity Troponin Assays for the Early Rule-out or Diagnosis of Acute Myocardial Infarction in People with Acute Chest Pain: A Systematic Review and Cost-Effectiveness Analysis, NIHR Journals Library. Health Technology Assessment No. 19.44.","DOI":"10.3310\/hta19440"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kip, M.M.A., Koffijberg, H., Moesker, M.J., IJzerman, M.J., and Kusters, R. (2017). The Cost-Utility of Point-of-Care Troponin Testing to Diagnose Acute Coronary Syndrome in Primary Care. BMC Cardiovasc. Disord., 17.","DOI":"10.1186\/s12872-017-0647-6"},{"key":"ref_45","first-page":"61","article-title":"Economic Evidence and Point-of-Care Testing","volume":"34","author":"Price","year":"2013","journal-title":"Clin. Biochem. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1136\/heartjnl-2012-302188","article-title":"Cost-Effectiveness of Presentation versus Delayed Troponin Testing for Acute Myocardial Infarction","volume":"98","author":"Thokala","year":"2012","journal-title":"Heart"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17150","article-title":"Randomised Assessment of Treatment Using Panel Assay of Cardiac Markers--Contemporary Biomarker Evaluation (RATPAC CBE)","volume":"17","author":"Collinson","year":"2013","journal-title":"Health Technol. Assess."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e013653","DOI":"10.1136\/bmjopen-2016-013653","article-title":"The Organisational Value of Diagnostic Strategies Using High-Sensitivity Troponin for Patients with Possible Acute Coronary Syndromes: A Trial-Based Cost-Effectiveness Analysis","volume":"7","author":"Greenslade","year":"2017","journal-title":"BMJ Open"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta15230","article-title":"The RATPAC (Randomised Assessment of Treatment Using Panel Assay of Cardiac Markers) Trial: A Randomised Controlled Trial of Point-of-Care Cardiac Markers in the Emergency Department","volume":"15","author":"Goodacre","year":"2011","journal-title":"Health Technol. Assess."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17010","article-title":"Systematic Review, Meta-Analysis and Economic Modelling of Diagnostic Strategies for Suspected Acute Coronary Syndrome","volume":"17","author":"Goodacre","year":"2013","journal-title":"Health Technol. Assess."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1553-2712.2011.01068.x","article-title":"Cost-Effectiveness of Point-Of-Care Biomarker Assessment for Suspected Myocardial Infarction: The Randomized Assessment of Treatment Using Panel Assay of Cardiac Markers (RATPAC) Trial","volume":"18","author":"Fitzgerald","year":"2011","journal-title":"Acad. Emerg. Med."},{"key":"ref_52","first-page":"E84","article-title":"Use of High-Sensitive Troponin T Assay for the Early Diagnosis of Acute Myocardial Infarction in Chest Pain Patients: An Economic Evaluation","volume":"32","author":"Vaidya","year":"2012","journal-title":"Med. Decis. Mak."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"E216","DOI":"10.1503\/cmaj.090578","article-title":"Effect of Point-of-Care Computer Reminders on Physician Behaviour: A Systematic Review","volume":"182","author":"Shojania","year":"2010","journal-title":"CMAJ"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by Representatives of 10 Societies and by Invited Experts) Developed with the Special Contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_55","unstructured":"National Clinical Guideline Centre (UK) (2014). Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease, National Institute for Health and Care Excellence. National Institute for Health and Clinical Excellence: Guidance."},{"key":"ref_56","unstructured":"SIGN (2020, April 07). 149 Risk Estimation and the Prevention of Cardiovascular Disease. Available online: https:\/\/www.sign.ac.uk\/sign-149-risk-estimation-and-the-prevention-of-cardiovascular-disease."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijcard.2004.08.042","article-title":"Management of Non-ST-Elevation Acute Coronary Syndromes: How Cost-Effective Are Glycoprotein IIb\/IIIA Antagonists in the UK National Health Service?","volume":"100","author":"Palmer","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2165\/00019053-200321160-00001","article-title":"Costs and Cost Effectiveness of Low Molecular Weight Heparins and Platelet Glycoprotein IIb\/IIIa Inhibitors: In the Management of Acute Coronary Syndromes","volume":"21","author":"Bosanquet","year":"2003","journal-title":"Pharmacoeconomics"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"539","DOI":"10.5603\/CJ.a2014.0005","article-title":"Feasibility of Home-Based Cardiac Telerehabilitation: Results of TeleInterMed Study","volume":"21","author":"Piotrowicz","year":"2014","journal-title":"Cardiol. J."},{"key":"ref_61","unstructured":"(2020, January 28). Telehealth for Acute and Chronic Care Consultations\u2014Abstract\u2014Europe PMC. Available online: https:\/\/europepmc.org\/article\/med\/31577401."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e16538","DOI":"10.2196\/16538","article-title":"Outcomes of a Heart Failure Telemonitoring Program Implemented as the Standard of Care in an Outpatient Heart Function Clinic: Pretest-Posttest Pragmatic Study","volume":"22","author":"Ware","year":"2020","journal-title":"J. Med. Internet Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.mayocp.2014.12.026","article-title":"Digital Health Interventions for the Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis","volume":"90","author":"Widmer","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/ejhf.1530","article-title":"Biomarker Guidance Allows a More Personalized Allocation of Patients for Remote Patient Management in Heart Failure: Results from the TIM-HF2 Trial","volume":"21","author":"Koehler","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.jacc.2017.08.010","article-title":"Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction","volume":"70","author":"Givertz","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/ajcp\/aqx066","article-title":"Variability and Error in Cardiac Troponin Testing","volume":"148","author":"Herman","year":"2017","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Adel Serhani, M., El Kassabi, H.T., Ismail, H., and Nujum Navaz, A. (2020). ECG Monitoring Systems: Review, Architecture, Processes, and Key Challenges. Sensors, 20.","DOI":"10.3390\/s20061796"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Amorim, V.J.P., Silva, M.C., and Oliveira, R.A.R. (2020). Software and Hardware Requirements and Trade-Offs in Operating Systems for Wearables: A Tool to Improve Devices\u2019 Performance. Sensors, 19.","DOI":"10.3390\/s19081904"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41746-019-0148-3","article-title":"Artificial Intelligence and Machine Learning in Clinical Development: A Translational Perspective","volume":"2","author":"Shah","year":"2019","journal-title":"NPJ Digit. Med."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Dias, D., and Silva Cunha, J.P. (2018). Wearable Health Devices\u2014Vital Sign Monitoring, Systems and Technologies. Sensors, 18.","DOI":"10.3390\/s18082414"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Majumder, S., Mondal, T., and Jamal Deen, M. (2017). Wearable Sensors for Remote Health Monitoring. Sensors, 17.","DOI":"10.3390\/s17010130"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1109\/TBME.2013.2244892","article-title":"Challenges and Opportunities in Cardiovascular Health Informatics","volume":"60","author":"Zhang","year":"2013","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Guk, K., Han, G., Lim, J., Jeong, K., Kang, T., Lim, E.-K., and Jung, J. (2019). Evolution of Wearable Devices with Real-Time Disease Monitoring for Personalized Healthcare. Nanomaterials, 9.","DOI":"10.3390\/nano9060813"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.trac.2016.06.015","article-title":"Nanomaterials-Based Electrochemical Immunosensors for Cardiac Troponin Recognition: An Illustrated Review","volume":"82","author":"Abdorahim","year":"2016","journal-title":"TrAC Trends Anal. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/elan.201300597","article-title":"Electrochemical Biosensors for the Determination of Cardiovascular Markers: A Review","volume":"26","author":"Pedrero","year":"2014","journal-title":"Electroanalysis"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bios.2015.03.062","article-title":"Graphene, Carbon Nanotubes, Zinc Oxide and Gold as Elite Nanomaterials for Fabrication of Biosensors for Healthcare","volume":"70","author":"Kumar","year":"2015","journal-title":"Biosens. Bioelectron."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1021\/acs.chemrev.6b00220","article-title":"Electrochemical Methods for the Analysis of Clinically Relevant Biomolecules","volume":"116","author":"Labib","year":"2016","journal-title":"Chem. Rev."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/AHCT.S138543","article-title":"Cardiac Troponin Biosensors: Where Are We Now?","volume":"4","author":"Upasham","year":"2018","journal-title":"Adv. Health Care Technol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1039\/C7LC00914C","article-title":"Wearable Sensors: Modalities, Challenges, and Prospects","volume":"18","author":"Heikenfeld","year":"2018","journal-title":"Lab Chip"},{"key":"ref_80","unstructured":"World Health Organization (2017). Global Diffusion of Ehealth: Making Universal Health Coverage Achievable, World Health Organization."},{"key":"ref_81","unstructured":"Newsroom (2020, April 07). Ehealth Action Plan 2012\u20132020: Innovative Healthcare for the 21st Century. Available online: https:\/\/ec.europa.eu\/digital-single-market\/en\/news\/ehealth-action-plan-2012-2020-innovative-healthcare-21st-century."},{"key":"ref_82","unstructured":"(2020, January 31). REGULATION (EU) 2016\/679 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL\u2014Of 27 April 2016\u2014On the Protection of Natural Persons with Regard to the Processing of Personal Data and on the Free Movement of Such Data, and Repealing Directive 95\/46\/EC (General Data Protection Regulation). 88. Available online: https:\/\/eur-lex.europa.eu\/eli\/reg\/2016\/679\/oj."},{"key":"ref_83","unstructured":"(2020, January 31). Directive 2011\/24\/EU of the European Parliament and of the Council of 9 March 2011 on the Application of Patients\u2019 Rights in Cross-Border Healthcare. 21. Available online: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/ALL\/?uri=CELEX%3A32011L0024."},{"key":"ref_84","unstructured":"(2020, January 31). REGULATION (EU) 2017\/745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL\u2014Of 5 April 2017\u2014On Medical Devices, Amending Directive 2001\/83\/EC, Regulation (EC) No 178\/2002 and Regulation (EC) No 1223\/2009 and Repealing Council Directives 90\/385\/EEC and 93\/42\/EEC. 175. Available online: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A32017R0745."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.trsl.2012.01.023","article-title":"Biomarkers: Hopes and challenges in the path from discovery to clinical practice","volume":"159","author":"Frangogiannis","year":"2012","journal-title":"Transl. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur. Heart J."}],"container-title":["Sensors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8220\/20\/17\/5006\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:06:26Z","timestamp":1760177186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8220\/20\/17\/5006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":86,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["s20175006"],"URL":"https:\/\/doi.org\/10.3390\/s20175006","relation":{},"ISSN":["1424-8220"],"issn-type":[{"value":"1424-8220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]}}}